Breaching the blood-brain barrier: Researchers may have solved 100-year-old puzzle

It turns out that adenosine receptor activation with Lexiscan , an A2A receptor agonist, can breach the blood brain barrier: This could be very useful for delivering brain cancer drugs or  antibodies  and has many other applications ( and potential dangers).
Enhanced by Zemanta

No comments: